Device Safety Information – DSI/2026/006

The MHRA is providing an update on defects previously identified with Belzer solutions. These included leakage and discolouration, resulting in fluid which was potentially contaminated and posed a risk of significant patient harm.

This DSI replaces advice in DSI/2023/005, which should no longer be followed. Corrective action has been taken by Carnamedica and Bridge to Life to resolve the issues identified and as a result the suspension to sales of the product has now been lifted.

Healthcare professionals should follow the instructions detailed in this update when using these solutions during organ donation and transplantation procedures.